Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignanciesAndrew M Brunner, Haesook T Kim, Erin Coughlin, et al.
Bone Marrow Transplantation|September 8, 2020
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host diseaseNatasha Kekre, Haesook T Kim, Julia Hofer, et al.
Blood|December 17, 2015
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHDAna C Alho, Haesook T Kim, Marie J Chammas, et al.
Blood Advances|April 3, 2019
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host diseaseJennifer S Whangbo, Haesook T Kim, Sarah Nikiforow, et al.
Blood Advances|April 27, 2022
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host diseaseJennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationDavid L Porter, Edwin P Alyea, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2016
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern YearsAreej El-Jawahri, Shuli Li, Joseph H Antin, et al.
Blood|December 21, 2013
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusionPavan Bachireddy, Ursula Hainz, Michael Rooney, et al.
Haematologica|May 27, 2014
Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantationKazuyuki Murase, Haesook T Kim, O R Gregory Bascug, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2010
Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignanciesAndrew M Brunner, Haesook T Kim, Erin Coughlin, et al.
Bone Marrow Transplantation|September 8, 2020
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host diseaseNatasha Kekre, Haesook T Kim, Julia Hofer, et al.
Blood|December 17, 2015
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHDAna C Alho, Haesook T Kim, Marie J Chammas, et al.
Blood Advances|April 3, 2019
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host diseaseJennifer S Whangbo, Haesook T Kim, Sarah Nikiforow, et al.
Blood Advances|April 27, 2022
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host diseaseJennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationDavid L Porter, Edwin P Alyea, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2016
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern YearsAreej El-Jawahri, Shuli Li, Joseph H Antin, et al.
Blood|December 21, 2013
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusionPavan Bachireddy, Ursula Hainz, Michael Rooney, et al.
Haematologica|May 27, 2014
Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantationKazuyuki Murase, Haesook T Kim, O R Gregory Bascug, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2010
Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Pageof 18